TISSUE INHIBITOR OF METALLOPROTEINASE-1, COLLAGENOLYTIC AND GELATINOLYTIC ACTIVITY IN LOOSE HIP ENDOPROSTHESES

TAKAGI M, KONTTINEN YT, KEMPPINEN P, SORSA T, Tschesche H, BLASER J, SUDA A, SANTAVIRTA S (1995)
JOURNAL OF RHEUMATOLOGY 22(12): 2285-2290.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ;
Abstract
Objective, To study tissue inhibitor of metalloproteinase 1 (TIMP-1) in relation to collagenolytic and gelatinolytic potential, namely dinitrophenyl-Pro-Gln-Gly-Ile-Ala-Gly-Gln-D-Arg (DNP-S) sensitive proteolytic activity, in loose total hip arthroplasty (THA) endoprostheses. Methods. Tissue localization of TIMP-1 was investigated immunohistochemically. TIMP-1 level of the periprosthetic tissues and fluid samples from 9 loose THA endoprostheses was measured by competitive ELISA, and DNP-S sensitive collagenolytic and gelatinolytic potential was evaluated by the degradation of synthetic DNP-S and reverse phase high performance liquid chromatography. Results. Immunohistochemical analysis revealed moderate to marked immunoreactivity of TIMP-1 in pseudosynovial lining cells, and weak to moderate immunoreactivity often in monocyte/macrophages, endothelial cells, and fibroblasts in both interface tissues between bone and implant and pseudocapsular tissues around the artificial joints. TIMP-1 level was low in interface tissue samples (795 +/- 203 ng/ml) compared to pseudosynovial fluid samples (2026 +/- 584 ng/ml). Degradation rate of the substrate was higher in interface tissue samples (56 +/- 6%) than in pseudocapsular tissue samples (32 +/- 4%) and pseudosynovial fluid samples (6 +/- 2%). Conclusion. Low TIMP-1 level combined with high percentage of degradation of synthetic substrate DNP-S leads to high collagenolytic and gelatinolytic activity in interface tissue samples. This may in part explain the weakening of periprosthetic connective tissue. Weakening Combined with cyclic mechanical loading may lead to loosening of THA endoprostheses.
Publishing Year
ISSN
PUB-ID

Cite this

TAKAGI M, KONTTINEN YT, KEMPPINEN P, et al. TISSUE INHIBITOR OF METALLOPROTEINASE-1, COLLAGENOLYTIC AND GELATINOLYTIC ACTIVITY IN LOOSE HIP ENDOPROSTHESES. JOURNAL OF RHEUMATOLOGY. 1995;22(12):2285-2290.
TAKAGI, M., KONTTINEN, Y. T., KEMPPINEN, P., SORSA, T., Tschesche, H., BLASER, J., SUDA, A., et al. (1995). TISSUE INHIBITOR OF METALLOPROTEINASE-1, COLLAGENOLYTIC AND GELATINOLYTIC ACTIVITY IN LOOSE HIP ENDOPROSTHESES. JOURNAL OF RHEUMATOLOGY, 22(12), 2285-2290.
TAKAGI, M., KONTTINEN, Y. T., KEMPPINEN, P., SORSA, T., Tschesche, H., BLASER, J., SUDA, A., and SANTAVIRTA, S. (1995). TISSUE INHIBITOR OF METALLOPROTEINASE-1, COLLAGENOLYTIC AND GELATINOLYTIC ACTIVITY IN LOOSE HIP ENDOPROSTHESES. JOURNAL OF RHEUMATOLOGY 22, 2285-2290.
TAKAGI, M., et al., 1995. TISSUE INHIBITOR OF METALLOPROTEINASE-1, COLLAGENOLYTIC AND GELATINOLYTIC ACTIVITY IN LOOSE HIP ENDOPROSTHESES. JOURNAL OF RHEUMATOLOGY, 22(12), p 2285-2290.
M. TAKAGI, et al., “TISSUE INHIBITOR OF METALLOPROTEINASE-1, COLLAGENOLYTIC AND GELATINOLYTIC ACTIVITY IN LOOSE HIP ENDOPROSTHESES”, JOURNAL OF RHEUMATOLOGY, vol. 22, 1995, pp. 2285-2290.
TAKAGI, M., KONTTINEN, Y.T., KEMPPINEN, P., SORSA, T., Tschesche, H., BLASER, J., SUDA, A., SANTAVIRTA, S.: TISSUE INHIBITOR OF METALLOPROTEINASE-1, COLLAGENOLYTIC AND GELATINOLYTIC ACTIVITY IN LOOSE HIP ENDOPROSTHESES. JOURNAL OF RHEUMATOLOGY. 22, 2285-2290 (1995).
TAKAGI, M, KONTTINEN, YT, KEMPPINEN, P, SORSA, T, Tschesche, Harald, BLASER, J, SUDA, A, and SANTAVIRTA, S. “TISSUE INHIBITOR OF METALLOPROTEINASE-1, COLLAGENOLYTIC AND GELATINOLYTIC ACTIVITY IN LOOSE HIP ENDOPROSTHESES”. JOURNAL OF RHEUMATOLOGY 22.12 (1995): 2285-2290.
This data publication is cited in the following publications:
This publication cites the following data publications:

12 Citations in Europe PMC

Data provided by Europe PubMed Central.

Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target.
Lin TH, Tamaki Y, Pajarinen J, Waters HA, Woo DK, Yao Z, Goodman SB., Acta Biomater 10(1), 2014
PMID: 24090989
In vitro effects of non-steroidal anti-inflammatory drugs on cytokine, prostanoid and matrix metalloproteinase production by interface membranes from loose hip or knee endoprostheses.
Syggelos SA, Giannopoulou E, Gouvousis PA, Andonopoulos AP, Aletras AJ, Panagiotopoulos E., Osteoarthr. Cartil. 15(5), 2007
PMID: 17188523
Effect of cobalt and chromium ions on MMP-1, TIMP-1, and TNF-alpha gene expression in human U937 macrophages: a role for tyrosine kinases.
Luo L, Petit A, Antoniou J, Zukor DJ, Huk OL, Liu RC, Winnik FM, Mwale F., Biomaterials 26(28), 2005
PMID: 15878362
Wear particulate and osteolysis.
Goodman S., Orthop. Clin. North Am. 36(1), 2005
PMID: 15542121
Quantitative analysis of mRNA expression of TIMPs in the periprosthetic interface tissue of loose hips by real-time PCR system.
Sasaki K, Takagi M, Mandelin J, Takei I, Santavirta S, Ida H, Ogino T, Konttinen YT., J. Biomed. Mater. Res. 58(6), 2001
PMID: 11745511
Development and characteristics of a synovial-like interface membrane around cemented tibial hemiarthroplasties in a novel rat model of aseptic prosthesis loosening.
Pap G, Machner A, Rinnert T, Horler D, Gay RE, Schwarzberg H, Neumann W, Michel BA, Gay S, Pap T., Arthritis Rheum. 44(4), 2001
PMID: 11315935
Expression of gelatinase A and its activator MT1-MMP in the inflammatory periprosthetic response to polyethylene.
Nawrocki B, Polette M, Burlet H, Birembaut P, Adnet JJ., J. Bone Miner. Res. 14(2), 1999
PMID: 9933484
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
Takei I, Takagi M, Santavirta S, Ida H, Hamasaki M, Ishii M, Fukushima S, Ogino T, Konttinen YT., J. Biomed. Mater. Res. 45(3), 1999
PMID: 10397973
Expression of tenascin-C in aseptic loosening of total hip replacement.
Konttinen YT, Li TF, Michelsson O, Xu JW, Sorsa T, Santavirta S, Imai S, Virtanen I., Ann. Rheum. Dis. 57(10), 1998
PMID: 9893574

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 8835563
PubMed | Europe PMC

Search this title in

Google Scholar